HLS Therapeutics Inc has seen notable price movement this week, contributing to a stronger performance overall despite a slight dip on Friday.
HLS Therapeutics Inc (HLS.TO) has experienced a week of positive momentum, with a 7.97% increase over the past week, culminating in a minor decline of 1.18% on Friday. The recent changes in the Board of Directors may have influenced investor sentiment, as the company positions itself for future growth within the health care sector.
Investor takeaway: Investors should consider the recent board changes and overall performance trends as they assess HLS Therapeutics Inc's potential in the health care market.
Advertisement
HLS Therapeutics Inc
HLS.TO
HLS.TO
HLS Therapeutics Inc
WealthAwesomeMarket cap
$129.93M
52W high
$5.64
52W low
$3.56
1W change
+7.97%
Beta
0.76
Analyst Price Targets
Based on analyst covering HLS · as of Oct 9, 2026
Wall Street analysts forecast HLS stock price to rise 78.3% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.49
+78.3% Upside
Previously C$7.52 on Oct 8, 2026
Current Price
C$4.20
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on HLS's historical volatility
30-Day Vol
47.9%
Annualized
90-Day Vol
38.4%
Annualized
Trend (90d)
+6.0%
Annualized drift
90d Mean
C$4.29
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$4.23 | C$3.59 – C$4.99 |
| 60 trading days | C$4.26 | C$3.37 – C$5.38 |
| 90 trading days | C$4.29 | C$3.22 – C$5.71 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
C$4.24
HLS Therapeutics' stock closed at C$4.24, reflecting a 7.97% increase over the past week, despite a minor pullback on Friday.
Bull case
The recent board changes could bring new ideas and strategies that might improve operational efficiency and increase shareholder value. This aligns with the positive outlook from analysts.
Bear case
Despite the recent gains, the company's negative profit margin and return on equity might concern risk-averse investors.
Price Action Overview
Advertisement
HLS Therapeutics Inc (HLS.TO) closed at C$4.24 on Friday, reflecting a decrease of 1.18% for the day. Despite this pullback, the stock has gained 7.97% over the past week and 11.11% over the last month, although it remains down 13.40% year-to-date.
Company News and Catalysts
On October 1, HLS Therapeutics announced changes to its Board of Directors. Such changes can often influence investor sentiment as they may signal a shift in strategy or focus for the company. This news likely contributed to the recent uptick in stock performance.
Technical Picture
Analyzing HLS Therapeutics’ technical indicators, the stock is currently trading above its 50-day moving average of C$3.94, indicating a positive short-term trend. However, it is slightly below the 200-day moving average of C$4.35, suggesting some resistance at higher levels. The stock has a 52-week range of C$3.56 to C$5.64, meaning it is currently at approximately 33% of its range. The beta of 0.76 indicates lower volatility compared to the broader market.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
